Effect of indapamide on blood pressure and glucose tolerance in non-insulin-dependent diabetes.
Ten hypertensive non-insulin-dependent diabetic patients were treated with the antihypertensive drug indapamide to assess its effect on glucose tolerance over 1 year. Both systolic and diastolic blood pressures fell significantly (p less than 0.001) over the first month of treatment, and no change in plasma glucose or plasma insulin levels during an oral glucose tolerance test occurred at any time. Indapamide is an effective antihypertensive drug and, in contrast to thiazide diuretics, has no adverse effect on glucose tolerance in non-insulin-dependent diabetic patients.
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism*; D001794:Blood Pressure / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D004232:Diuretics / Q000627:therapeutic use*; D005951:Glucose Tolerance Test; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy; D007190:Indapamide / Q000009:adverse effects / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D008875:Middle Aged
D000959:Antihypertensive Agents; D001786:Blood Glucose; D004232:Diuretics; D007328:Insulin; D007190:Indapamide